An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen

Archives of Pharmacal Research

Volumn 34, Issue 6, 2011, Pages 919-929

  Čalija, Bojan ^a   Cekić, Nebojsa ^b   Savić, Snežana ^a   Krajišnik, Danina ^a   Daniels, Rolf ^c   Milić, Jela ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b R and D Sector ^*  (Serbia)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Alginate chitosan microparticles; Experimental design; Naproxen; Sustained release

Indexed keywords

ALGINIC ACID; CHITOSAN; NAPROXEN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; EXPERIMENTAL DESIGN; FEASIBILITY STUDY; GELATION; MOLECULAR WEIGHT; PARTICLE SIZE; PH; SIMULATION; SMALL INTESTINE; STOMACH;

ADMINISTRATION, ORAL; ALGINATES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEASIBILITY STUDIES; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEN-ION CONCENTRATION; MICROSPHERES; MOLECULAR WEIGHT; NAPROXEN; PARTICLE SIZE; SOLUBILITY; TIME FACTORS;

EID: 79960227585     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0609-y     Document Type: Article

References (31)

1. F. Acartürk S. Takka 1999 Calcium alginate microparticles for oral administration: II. Effect of formulation factors on drug release and drug entrapment efficiency J. Microencapsul. 16 291 301 10340215 10.1080/ 026520499289013 (Pubitemid 29191813)
2. C. S. Brazel N. A. Peppas 1999 Mechanisms of solute and drug transport in relaxing, swellable, hydrophilic glassy polymers Polymer 40 3383 3398 10.1016/S0032-3861(98)00546-1 1:CAS:528:DyaK1MXhvFehu7o%3D (Pubitemid 30122557)
3. A. Cárdenas W. Argüelles-Monal F. M. Goycoolea I. Higuera-Ciapara C. Peniche 2003 Diffusion through membranes of the polyelectrolyte complex of chitosan and alginate Macromol. Biosci. 3 535 539 10.1002/mabi.200300031 (Pubitemid 37309677)
4. T. Çaykara S. Demirci M. S. Eroǧlu O. Güven 2005 Poly(ethylene oxide) and its blends with sodium alginate Polymer 46 10750 10757 10.1016/j.polymer.2005.09.041 (Pubitemid 41530667)
5. N. D. Cekić J. R. Milić S. D. Savić M. M. Savić Z. Jović R. Daniels 2009 Influence of the preparation procedure and chitosan type on physicochemical properties and release behavior of alginate-chitosan microparticles Drug Dev. Ind. Pharm. 35 1092 1102 19365778 10.1080/03639040902774164
6. Y. N. Dai P. Li J. P. Zhang A. Q. Wang Q. Wei 2008 Swelling characteristics and drug delivery properties of nifedipine-loaded pH sensitive alginate-chitosan hydrogel beads J. Biomed. Mater. Res. B Appl. Biomater. 86 493 500
7. Y. Dong Y. Ruan H. Wang Y. Zhao D. Bi 2004 Studies on glass transition temperature of chitosan with four techniques J. Appl. Polym. Sci. 93 1553 1558 10.1002/app.20630 1:CAS:528:DC%2BD2cXlvVans7Y%3D (Pubitemid 38896271)
8. C. Eskilson 1985 Controlled release by microencapsulation Manufacturing Chemist. 56 33 39
9. A. P. Ferreira A. J. Almeida 2004 Cross-linked alginategelatine beads: a new matrix for controlled release of pindolol J. Control. Release 97 431 439 (Pubitemid 38802945)
10. O. Gåserød O. Smidsrød G. Skjåk-Bræk 1998 Microcapsules of alginate-chitosan-I. A quantitative study of the interaction between alginate and chitosan Biomaterials 19 1815 1825 9855182 10.1016/S0142-9612(98)00073-8 (Pubitemid 28519963)
11. G. T. Grant E. R. Morris D. A. Rees P. J. C. Smith D. Thom 1973 Biological interactions between polysaccharides and divalent cations: the egg-box model FEBS Lett. 32 195 198 10.1016/0014-5793(73)80770-7 1:CAS:528:DyaE3sXks1alur8%3D
12. T. Higuchi 1963 Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices J. Pharm. Sci. 52 1145 1149 14088963 10.1002/jps.2600521210 1:CAS:528: DyaF2cXlt1Whsg%3D%3D
13. M. L. Huguet E. Dellacherie 1996 Calcium alginate beads coated with chitosan: effect of the structure of encapsulated materials on their release Process Biochem. 31 745 751 10.1016/S0032-9592(96)00032-5 1:CAS:528: DyaK28XlvFSkt7c%3D (Pubitemid 27061509)
14. A. Iruín M. Fernández-Arévalo J. Alvarez-Fuéntes A. Fini M. A. Holgado 2005 Elaboration and "in vitro" characterization of 5-ASA beads Drug Dev. Ind. Pharm. 31 231 239 15773290 10.1081/DDC-200047813 (Pubitemid 40315718)
15. C.-K. Kim E.-J. Lee 1992 The controlled release of blue dextran from alginate beads Int. J. Pharm. 79 11 19 10.1016/0378-5173(92)90088-J 1:CAS:528:DyaK38XmslSqug%3D%3D
16. S. J. Kim S. G. Yoon S. I. Kim 2004 Synthesis and characteristics of interpenetrating polymer network hydrogels composed of alginate and poly(diallydimethylammonium chloride) J. Appl. Polym. Sci. 91 3705 3709 10.1002/app.13615 1:CAS:528:DC%2BD2cXhtFKmt78%3D (Pubitemid 38287229)
17. R. W. Korsmeyer R. Gurny E. Doelker P. Buri N. A. Peppas 1983 Mechanisms of solute release from porous hydrophilic polymers Int. J. Pharm. 15 25 35 10.1016/0378-5173(83)90064-9 1:CAS:528:DyaL3sXksVens7Y%3D (Pubitemid 13092121)
18. Kramer, J. and Blume, H., Biopharmaceutical aspects of multiparticulates. In Ghebre-Sellasie, Y. (Ed.). Multiparticulate Oral Drug Delivery. Marcel Dekker, New York, pp. 307-332, (1994).
19. J. M. Llabot R. H. Manzo D. A. Allemandi 2004 Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system Int. J. Pharm. 276 59 66 15113614 10.1016/j.ijpharm.2004.02.006 1:CAS:528:DC%2BD2cXjtlyqu74%3D (Pubitemid 38542988)
20. M. Maghsoodi 2009 Physicomechanical properties of naproxenloaded microparticles prepared from Eudragit L100 AAPS PharmSciTech 10 120 128 19184624 10.1208/s12249-009-9186-5 1:CAS:528:DC%2BC3cXotV2mtb4%3D
21. A. Martinsen G. Skjåk-Bræk O. Smidsrød 1989 Alginate as immobilization materials: I. Correlation between chemical and physical properties of alginate gel beads Biotechnol. Bioeng. 33 79 89 18587846 10.1002/bit.260330111 1:CAS:528:DyaL1MXlsF2lsQ%3D%3D (Pubitemid 19010127)
22. E. R. Morris D. A. Rees D. Thom J. Boyd 1978 Chiroptical and stoichiometric evidence of a specific, primary dimerisation process in alginate gelation Carbohydr. Res. 66 145 154 10.1016/S0008-6215(00)83247-4 1:CAS:528:DyaE1cXlvFaktbc%3D
23. Y. Murata T. Maeda E. Miyamoto S. Kawashima 1993 Preparation of chitosan-reinforced alginate gel beads - effects of chitosan on gel matrix erosion Int. J. Pharm. 96 139 145 10.1016/0378-5173(93)90221-Z 1:CAS:528:DyaK3sXmtFSmurs%3D (Pubitemid 23233279)
24. C. G. T. Neto J. A. Giacometti A. E. Job F. C. Ferreira J. L. C. Fonseca M. R. Pereira 2005 Thermal Analysis of Chitosan Based Networks Carbohydr. Polym. 62 97 103 10.1016/j.carbpol.2005.02.022 1:CAS:528:DC%2BD2MXhtFKmtL7O (Pubitemid 41543046)
25. F. J. Otero-Espinar S. Anguiano-Igea J. Blanco-Méndez J. L. Vila-Jato 1991 Reduction in the ulcerogenicity of naproxen by complexation with β-cyclodextrin Int. J. Pharm. 70 35 41 10.1016/0378-5173(91)90161-G 1:CAS:528:DyaK3MXktlGmtbY%3D
26. N. A. Peppas J. J. Sahlin 1989 A simple equation for the description of solute release. III. Coupling of diffusion and relaxation Int. J. Pharm. 57 169 172 10.1016/0378-5173(89)90306-2 1:CAS:528:DyaK3cXhtVClu74%3D (Pubitemid 20011841)
27. A. Polk B. Amsden K. De Yao T. Peng M. F. A. Goosen 1994 Controlled release of albumin from chitosan-alginate microcapsules J. Pharm. Sci. 83 178 185 8169785 10.1002/jps.2600830213 1:CAS:528:DyaK2cXmt1Witg%3D%3D (Pubitemid 24224173)
28. A. J. Ribeiro R. J. Neufeld P. Arnaud J. C. Chaumeil 1999 Microencapsulation of lipophilic drugs in chitosancoated alginate microspheres Int. J. Pharm. 187 115 123 10502618 10.1016/S0378-5173(99)00173-8 1:CAS:528:DyaK1MXmt1SgsLY%3D (Pubitemid 29435978)
29. F. A. Simsek-Ege G. M. Bond J. Stringer 2003 Polyelectrolyte complex formation between alginate and chitosan as a function of pH J. Appl. Polym. Sci. 88 346 351 10.1002/app.11989 1:CAS:528:DC%2BD3sXhsFKntLg%3D (Pubitemid 36282007)
30. Sweetman, S. C., Martindale: The Complete Drug Reference. Pharmaceutical Press, London, pp. 60, (2002).
31. H. H. Tønnesen J. Karlsen 2002 Alginate in drug delivery systems Drug Dev. Ind. Pharm. 28 621 630 12149954 10.1081/DDC-120003853 (Pubitemid 34809561)